ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2083

Evaporative Dry-Eye Disease and Aqueous Deficient Dry-Eye Disease Associated with Fibromyalgia

William Pachas1, Jack Greiner2,3,4,5 and Paula Oliver2,3,4,6, 1Center for Rheumatology, Osteoporosis and Fibromyalgia, Boston, MA, 2The Schepens Eye Research Institute, Boston, MA, 3Massachusetts Eye and Ear Infirmary, Boston, MA, 4Harvard Medical School, Boston, MA, 5The Boston Ocular Surface Center, Boston, ME, 6The Boston Ocular Surface Center, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Research Focus

Session Type: Abstract Submissions (ACR)

Background/Purpose Fibromyalgia (FM) patients with ocular discomfort often describe symptoms characteristic of dry eye diseases, but frequently do not fulfill criteria diagnostic of Sjögrens syndrome. Thus, ophthalmologic subjective and objective testing were performed to (1) establish the association of FM with dry eye diseases and (2) attempt to identify the type(s) of dry eye diseases associated with FM.

Methods Consecutive patients (n=30) meeting American College of Rheumatology criteria for FM were evaluated as part of a comprehensive rheumatological examination. Subjective evaluation employed dry eye questionnaires, Ocular Surface Disease Index (OSDI) and Standard Patient Evaluation of Eye Dryness (SPEED). Objective tests included determination of minimum tearfilm lipid layer thickness (LLT), tearfilm osmolarity (TOSM), tearfilm break-up time (TBUT), Schirmer tear test (STT), corneal fluorescein-staining, and meibomian gland assessment (MGA) scores.

Results Measurements were compared with widely accepted “Normal Values” (NV). OSDI 32.38±SD 20.7 (range, 2.27-79.16) 60% higher than NV(<13); SPEED 11.38±7.1 (range, 0-23.5) 47% higher than NV (≤6); LLT 49.72±17.2 nm (range, 28-90) 38% lower than NV (≤80nm); TOSM 312.2±14.1 mOsm/l (range, 290-341) higher than NV (300 mOsm); TBUT 5.01±3.1 sec (range, 1-15.24) 50% lower than ≥(10 sec); STT 6.02±3.9 nm (range, 0-11.5) 40% lower than NV (≥10 mm); and MGA scores 11.70±5.1 (range, 4-27) ­­lower than NV(>12).

Conclusion Fibromyalgia patients demonstrate evidence for both evaporative and aqueous-deficient dry eye diseases. FM patients should be routinely questioned for signs or symptoms of dry eye disease(s) and referred for a comprehensive evaluation to determine the type(s) of their dry eye disease(s) in order to recommend appropriate treatment(s).


Disclosure:

W. Pachas,
None;

J. Greiner,
None;

P. Oliver,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaporative-dry-eye-disease-and-aqueous-deficient-dry-eye-disease-associated-with-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology